Spots Global Cancer Trial Database for Clinical Trial for Ovarian Cancer (OvaRex®)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Trial for Ovarian Cancer (OvaRex®)
Official Title: A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex® MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin
Study ID: NCT00050375
Conditions
Interventions
Study Description
Brief Summary: This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.
Detailed Description: This a Phase III, double-blind, placebo-controlled, multi-center study of intravenous OvaRex® MAb-B43.13 as post-chemotherapy consolidation for epithelial carcinoma of ovarian, tubal, or peritoneal origin.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Comprehensive Cancer Institute, Huntsville, Alabama, United States
Western Regional Community Clinical Oncology Program, Phoenix, Arizona, United States
Little Rock Hematology Oncology Assoc., Little Rock, Arkansas, United States
St. Jude Medical Center, Fullerton, California, United States
Wilshire Oncology Medical Group, La Verne, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
UCLA School of Medicine, Los Angeles, California, United States
Gynecologic Oncology Associates, Newport Beach, California, United States
University of California, Irvine, Orange, California, United States
Sharp Memorial Hospital, San Diego, California, United States
Stanford University, Stanford, California, United States
Rocky Mountain Cancer Center-Midtown, Denver, Colorado, United States
University of Connecticut Cancer Center, Farmington, Connecticut, United States
Northwestern Connecticut Oncology Hematology Associates, LLP, Torrington, Connecticut, United States
Florida Gynecologic Oncology, Fort Myers, Florida, United States
Florida Hospital Cancer Institute, Orlando, Florida, United States
Pensacola Research Consultants, Pensacola, Florida, United States
H. Lee Moffitt Cancer Center and Research, Tampa, Florida, United States
Medical College of Georgia, Augusta, Georgia, United States
The University of Chicago Hospitals, Chicago, Illinois, United States
St. Vincent Gynecologic Oncology, Indianapolis, Indiana, United States
Michiana Hematology Oncology PC, South Bend, Indiana, United States
Brown Cancer Center, Louisville, Kentucky, United States
Louisville Oncology, Louisville, Kentucky, United States
Lake Charles Medical Surgical Clinic, Lake Charles, Louisiana, United States
Hematology and Oncology Specialists, New Orleans, Louisiana, United States
The Harry and Jeanette Weinberg Cancer Institute, Baltimore, Maryland, United States
New England Medical Center, Boston, Massachusetts, United States
Women's Specialty Center, Jackson, Mississippi, United States
Ellis Fischel Cancer Center, Columbia, Missouri, United States
Jersey Shore Medical Center, Neptune, New Jersey, United States
North Shore University Hospital, Manhasset, New York, United States
St. Vincent's Comprehensive Cancer Center, New York City, New York, United States
Nyack Hospital, Nyack, New York, United States
SUNY-HSC Syracuse, Crouse Hospital, Syracuse, New York, United States
Blumenthal Cancer Center, Charlotte, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
University Hospital - Health Systems, Cleveland, Ohio, United States
GYN Oncology and Pelvic Surgery Associates, Columbus, Ohio, United States
ProMedica Health Systems, Toledo, Ohio, United States
Medical College of Ohio Cancer Institute, Toledo, Ohio, United States
Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, United States
Northwest Cancer Specialists-Northrup, Portland, Oregon, United States
Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
Brown University School of Medicine, Providence, Rhode Island, United States
South Carolina Oncology Associates, Columbia, South Carolina, United States
Gynecologic Oncology Research and Development, Greenville, South Carolina, United States
Chattanooga GYN Oncology, Chattanooga, Tennessee, United States
West Clinic, PC, Memphis, Tennessee, United States
Arlington Cancer Center, Arlington, Texas, United States
Southwest Regional Cancer Center, Austin, Texas, United States
Univ. of Texas SW Medical Center at Dallas, Dallas, Texas, United States
Texas Oncology, PA, Dallas, Texas, United States
Texas Oncology, Fort Worth, Texas, United States
The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States
Utah Cancer Specialists, Salt Lake City, Utah, United States
University of Virginia Cancer Center, Charlottesville, Virginia, United States
VA Oncology Associates, Norfolk, Virginia, United States
Carilion GYN Oncology Associates, Roanoke, Virginia, United States
Swedish Medical Center, Seattle, Washington, United States
Cancer Care Northwest, Spokane, Washington, United States
Northwest Cancer Specialists-Vancouver, Vancouver, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
